/Investor DB

YuanBio Venture Capital — 2026 Investments

2 investments dated 2026 · listed companies and verified rows first · show all

Zai Labzailaboratory.comin𝕏NASDAQ: ZLABOct 2026

Zai Lab is a global biopharmaceutical company developing and commercializing therapies in oncology, immunology, neuroscience, and infectious disease, with operations in China and the United States.

BiotechHealthtechMedical Devices

Samantha (Ying) Du(Founder, Chief Executive Officer, Chairperson of the Board of Directors)inYajing Chen(Chief Financial Officer)inRafael G. Amado(President, Head of Global Research and Development)inF. Ty Edmondson(Chief Legal Officer)inJosh Smiley(President and Chief Operating Officer)Samantha Du(Founder)

Co-investorsQiming Venture PartnersVivo CapitalAdvantech CapitalHongShan Capital GroupKleiner PerkinsSequoia Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Legend Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.